Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

4.25
Delayed Data
As of Jan 23
 +0.05 / +1.19%
Today’s Change
4.10
Today|||52-Week Range
10.50
-8.60%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close4.20
Today’s open4.25
Day’s range4.10 - 4.35
Volume313,334
Average volume (3 months)491,261
Market cap$229.9M
Dividend yield--
Data as of 4:00pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+15.85%
Earnings growth (this year)-1.81%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,573.69
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...-0.09-0.50%
CMRXChimerix Inc+0.64+13.06%
ZGNXZogenix Inc-0.45-5.03%
ESPREsperion Therapeutic...-0.11-0.99%
Data as of 4:00pm ET, 01/23/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$152.4K
Annual profit (last year)-$62.9M
Net profit margin-41,310.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts


Search for Jobs